TC BIOPHARM (HOLDINGS) PLC Share-based Payment Arrangement, Expense
TC BIOPHARM (HOLDINGS) PLC reported Share-based Payment Arrangement, Expense of GBP 1.01 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-09
| Period end | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|
| 2024-12-31 | 1.01M GBP 20-F · filed 2025-05-09 | |
| 2024-06-30 | 908.61K GBP 6-K · filed 2024-11-25 | |
| 2023-12-31 | 444.46K GBP 20-F · filed 2025-05-09 | |
| 2023-06-30 | 142.32K GBP 6-K · filed 2024-11-25 | |
| 2022-12-31 | 1.12M GBP 20-F · filed 2025-05-09 |